Annerén C, Welsh M
Department of Medical Cell Biology, Biomedicum Uppsala University, Sweden.
Growth Factors. 2000;17(4):233-47. doi: 10.3109/08977190009028969.
Bsk/Iyk, a murine non-receptor-tyrosine kinase which is expressed in fetal and adult islet of Langerhans was previously found to decrease NIH3T3 cell proliferation when expressed as a Y497/504F-mutant. We presently wanted to determine the effects of Bsk/Iyk on the proliferation of insulin producing cells. Cells expressing Bsk/IykY497/504F and Bsk/IykY504F display a decreased proliferation rate and express higher levels of the cell cycle inhibitor p27/Kip1 compared to control cells. These mutants also conferred diminished cell viability in response to INF-gamma and IL-1beta and contain higher levels of glucagon mRNA. Wild-type Bsk/Iyk is mainly localized at the plasma membrane whereas mutant Bsk/Iyk can enter the nucleus. In vitro kinase reactions using an exogenous substrate indicate a complicated mode of regulation of kinase activity by Y497 and Y504 with the latter being homologous to Y527 in pp60c-Src. These findings suggest that Bsk/Iyk might play a role in inhibiting cell proliferation, transducing cytokine-induced cytotoxicity and regulating hormone production of endocrine pancreatic cells.
Bsk/Iyk是一种小鼠非受体酪氨酸激酶,在胎儿和成年朗格汉斯胰岛中表达,先前发现当以Y497/504F突变体形式表达时,它会降低NIH3T3细胞的增殖。我们目前想确定Bsk/Iyk对胰岛素产生细胞增殖的影响。与对照细胞相比,表达Bsk/IykY497/504F和Bsk/IykY504F的细胞显示出增殖速率降低,并表达更高水平的细胞周期抑制剂p27/Kip1。这些突变体在对INF-γ和IL-1β的反应中也导致细胞活力降低,并且含有更高水平的胰高血糖素mRNA。野生型Bsk/Iyk主要定位于质膜,而突变型Bsk/Iyk可以进入细胞核。使用外源底物的体外激酶反应表明,Y497和Y504对激酶活性的调节模式复杂,后者与pp60c-Src中的Y527同源。这些发现表明,Bsk/Iyk可能在抑制细胞增殖、转导细胞因子诱导的细胞毒性以及调节内分泌胰腺细胞的激素产生中发挥作用。